Steven Shallcross is the founder of Theriva Biologics. He served as lead partner on a transaction with VCN Biosciences in March 2022.
Steven Shallcross is the Chief Executive Officer, Chief Financial Officer, and Director of Theriva Biologics, a clinical-stage biotechnology company developing therapeutics for cancer and related diseases. He served as lead partner on a transaction with VCN Biosciences in March 2022.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide